PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18234966-2	2008	Here, we show that p53(Ala135Val/wt) mice developed ovarian tumors significantly more rapidly than their wild-type littermates after 7,12-dimethylbenz(a)anthracene (DMBA) treatment.	anthracene	153-163	transformation related protein 53, pseudogene	Mus musculus	19-22	
18059331-2	2008	Deletion of the p19/Arf or p53 tumor suppressor genes accelerates malignant progression and metastatic spread of 7,12-dimethylbenz(a)anthracene (DMBA)/12-O-tetradecanoyl-phorbol-13-acetate (TPA)-induced squamous cell carcinomas, providing a model system to address mechanisms of metastasis.	anthracene	133-143	transformation related protein 53, pseudogene	Mus musculus	27-30	
17925458-2	2008	Previous studies have reported that 7,12-dimethylbenz[a]anthracene (DMBA)-induced bone marrow toxicity is p53-dependent in vivo.	anthracene	56-66	transformation related protein 53, pseudogene	Mus musculus	106-109	
9849426-1	1998	The immunoreactivity of p53 protein was studied in relation to tumour development, histopathological characteristics, cell proliferation, and basement membrane organisation following the induction of skin carcinogenesis in tumour-sensitive and -resistant mouse strains by ultraviolet (UV) irradiation or 7,12-dimethylbenz(a)anthracene (DMBA).	anthracene	324-334	transformation related protein 53, pseudogene	Mus musculus	24-27	
16613839-1	2006	Previous studies in our laboratory demonstrated that 7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol-13-acetate (DMBA/TPA) treatment induced apoptosis and mitochondrial translocation of the tumor suppressor p53 in a mouse skin carcinogenesis model, suggesting that oncogenic versus cell death signaling involve a common mediator.	anthracene	73-83	transformation related protein 53, pseudogene	Mus musculus	216-219	
15542785-0	2004	Modulation of p53 in 7,12-dimethylbenz[a]anthracene-induced skin tumors by diallyl sulfide in Swiss albino mice.	anthracene	41-51	transformation related protein 53, pseudogene	Mus musculus	14-17	
15542785-4	2004	In the present study, modulation in p53 expression by topical application of DAS was recorded in 7,12-dimethylbenz[a]anthracene (DMBA)-induced skin tumors in Swiss albino mice.	anthracene	117-127	transformation related protein 53, pseudogene	Mus musculus	36-39	
12730609-0	2003	7,12-Dimethylbenz[a]anthracene-induced bone marrow toxicity is p53-dependent.	anthracene	20-30	transformation related protein 53, pseudogene	Mus musculus	63-66	
7576102-0	1995	Delay of dimethylbenz[a]anthracene-induced mammary tumorigenesis in transgenic mice by apoptosis induced by an unusual mutant p53 protein.	anthracene	24-34	transformation related protein 53, pseudogene	Mus musculus	126-129	
8142019-0	1994	Infrequent p53 mutations in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in BALB/c and p53 hemizygous mice.	anthracene	48-58	transformation related protein 53, pseudogene	Mus musculus	11-14	
8142019-0	1994	Infrequent p53 mutations in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in BALB/c and p53 hemizygous mice.	anthracene	48-58	transformation related protein 53, pseudogene	Mus musculus	96-99	
8142019-2	1994	In 13 mammary tumors from 7,12-dimethylbenz[a]anthracene (DMBA)-treated BALB/c mice were immunohistochemically analyzed for overexpression of p53; p53 protein was not detectable.	anthracene	46-56	transformation related protein 53, pseudogene	Mus musculus	142-145	
26687588-2	2016	7,12-Dimethylbenz(a)anthracene ( DMBA), a genotoxic agent, reacts with DNA directly, inducing p53-dependent cytotoxicity resulting in cell death by apoptosis or giving rise to cancer.	anthracene	20-30	transformation related protein 53, pseudogene	Mus musculus	94-97